Craniofacial pain is among the most common chronic pain conditions, affecting more than one-fifth of the U.S. population 1. With this milestone, Curonix advances its mission to drive full-body PNS ...
Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”) a Carlsbad, California-based company that markets a minimally invasive neurostimulation implant for the management of chronic intractable ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.
LOS ANGELES, March 4, 2025 /PRNewswire/ -- Nervonik, Inc. (Nervonik), a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system, has successfully closed a $13 ...
Centennial Spine and Pain joined us at the New Mexico Living studio on Monday for our weekly health segment. This week, Dr. John Watkins told us all about peripheral nerve stimulators – what they are, ...
DURHAM, N.C., July 30, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (BVS), a global leader in innovations for active healing, announced today a significant milestone with the U.S. Food and Drug ...
A new tool to model peripheral nerve stimulation rapidly discovered optimal electrical waveforms (white traces) which, when delivered through the metal contacts of a cuff electrode placed on the vagus ...
The US Food and Drug Administration has approved Abbott's Proclaim XR spinal cord stimulation (SCS) system for the treatment of patients with diabetic peripheral neuropathy (DPN), the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback